BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 17135575)

  • 1. Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells.
    Zhou W; Blackwell TS; Goleniewska K; O'Neal JF; Fitzgerald GA; Lucitt M; Breyer RM; Peebles RS
    J Leukoc Biol; 2007 Mar; 81(3):809-17. PubMed ID: 17135575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of IL-12 and IL-18 in skewing tumor-reactive T-cell responses towards a type 1 pattern.
    Li Q; Carr AL; Donald EJ; Skitzki JJ; Okuyama R; Stoolman LM; Chang AE
    Cancer Res; 2005 Feb; 65(3):1063-70. PubMed ID: 15705908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
    Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
    J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes.
    Heo Y; Lee WT; Lawrence DA
    Toxicol Sci; 1998 Jun; 43(2):172-85. PubMed ID: 9710959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance.
    Cheng X; Chen Y; Xie JJ; Yao R; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH; Cheng Y
    J Mol Cell Cardiol; 2008 Aug; 45(2):168-75. PubMed ID: 18502445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets.
    Brinkmann V; Kristofic C
    J Immunol; 1995 Oct; 155(7):3322-8. PubMed ID: 7561025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production.
    Ramer-Quinn DS; Baker RA; Sanders VM
    J Immunol; 1997 Nov; 159(10):4857-67. PubMed ID: 9366411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
    Lin SJ; Cheng PJ; Hsiao SS
    Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity.
    Nakajima S; Honda T; Sakata D; Egawa G; Tanizaki H; Otsuka A; Moniaga CS; Watanabe T; Miyachi Y; Narumiya S; Kabashima K
    J Immunol; 2010 May; 184(10):5595-603. PubMed ID: 20400695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Th1 cytokines by Leuconostoc mesenteroides subsp. mesenteroides (KCTC 3100) under Th2-type conditions and the requirement of NF-kappaB and p38/JNK.
    Kang H; Myung EJ; Ahn KS; Eom HJ; Han NS; Kim YB; Kim YJ; Sohn NW
    Cytokine; 2009 May; 46(2):283-9. PubMed ID: 19299163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine production by naive and primary effector CD4+ T cells exposed to norepinephrine.
    Ramer-Quinn DS; Swanson MA; Lee WT; Sanders VM
    Brain Behav Immun; 2000 Dec; 14(4):239-55. PubMed ID: 11120594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells.
    Zhou W; Hashimoto K; Goleniewska K; O'Neal JF; Ji S; Blackwell TS; Fitzgerald GA; Egan KM; Geraci MW; Peebles RS
    J Immunol; 2007 Jan; 178(2):702-10. PubMed ID: 17202330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hydroxymethylglutaryl-coenzyme a reductase reduces Th1 development and promotes Th2 development.
    Hakamada-Taguchi R; Uehara Y; Kuribayashi K; Numabe A; Saito K; Negoro H; Fujita T; Toyo-oka T; Kato T
    Circ Res; 2003 Nov; 93(10):948-56. PubMed ID: 14563711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
    Marks E; Verolin M; Stensson A; Lycke N
    Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB.
    Cho ML; Ju JH; Kim KW; Moon YM; Lee SY; Min SY; Cho YG; Kim HS; Park KS; Yoon CH; Lee SH; Park SH; Kim HY
    Immunol Lett; 2007 Jan; 108(1):88-96. PubMed ID: 17161467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WSX-1 over-expression in CD4(+) T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation.
    Takeda A; Hamano S; Shiraishi H; Yoshimura T; Ogata H; Ishii K; Ishibashi T; Yoshimura A; Yoshida H
    Int Immunol; 2005 Jul; 17(7):889-97. PubMed ID: 15908443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of electroacupuncture on TH1/TH2 cytokine mRNA expression and mitogen-activated protein kinase signaling pathways in the splenic T cells of traumatized rats.
    Wang K; Wu H; Wang G; Li M; Zhang Z; Gu G
    Anesth Analg; 2009 Nov; 109(5):1666-73. PubMed ID: 19843806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon gamma enhances both in vitro and in vivo priming of CD4+ T cells for IL-4 production.
    Bocek P; Foucras G; Paul WE
    J Exp Med; 2004 Jun; 199(12):1619-30. PubMed ID: 15210741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment.
    Okamoto I; Iwaki K; Koya-Miyata S; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Clin Immunol; 2002 May; 103(2):132-44. PubMed ID: 12027418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 costimulation promotes the production of Th2 cytokines.
    Rulifson IC; Sperling AI; Fields PE; Fitch FW; Bluestone JA
    J Immunol; 1997 Jan; 158(2):658-65. PubMed ID: 8992981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.